DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road) — Stella

View on ClinicalTrials.gov

Recruiting

Back to Hiv trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

France

CHU de Caen, Caen

CHU Orléans, Orléans

CHU Rouen, Rouen

CH Tourcoing, Tourcoing

Key details

Phase

Safety & dosing

Sponsor

University Hospital, Caen

Collaborators

Merck Sharp & Dohme LLC

Enrollment target

~32 participants

Started

February 2024

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.